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Neurogranin (Ng) is a neural-specific, calmodulin (CaM)-binding protein that is phosphorylated by protein 
kinase C (PKC). Although its biochemical property has been well characterized, the physiological function of Ng 
needs to be elucidated. In the present study, we performed proteomics analysis of the induced compositional 
changes due to the expression of Ng in murine neuroblastoma (Neuro-2a) cells using isotope coded affinity tags 
(ICAT) combined with 2-dimensional liquid chromatography/tandem mass spectrometry (2D-LC/MS/MS). We 
found that 40% of identified proteins were down-regulated and most of these proteins are microtubule compo-
nents and associated proteins that mediated neurite outgrowth. Western blot experiments confirmed the expres-
sion of α-tubulin and microtubule- associated protein 1B (MAP 1B) was dramatically reduced in Neuro-2a-Ng 
cells compared to control. Cell morphology of Neuro-2a-Ng showed far less neurites than the control. Serum 
deprivation induced the extension of only one or two long neurites per cell in Neuro-2a-Ng, contrasting to the 
extension of multiple neurites per control cell. Ng may be linked to neurite formation by affecting expression of 
several microtubule related proteins. Furthermore, the PKC activator (PMA) induced an enhanced ERK1/2 ac-
tivity in the cells that expressed Ng. The mutation of Ng at S36A caused sustained increase of ERK1/2 activity, 
whereas the ERK1/2 activity in mutation at I33Q showed no difference compared to wild type Ng, suggesting 
the phosphorylation of Ng but not the CaM /Ng interaction plays an important role in ERK activation. Ng may 
be involved in neuronal growth and differentiation via PKC and ERK1/2 signaling pathways. 
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1.  INTRODUCTION 
Neurogranin (Ng) is among the most abundant 
proteins known to bind calmodulin (CaM) in a 
Ca2+-sensitive way in the brain [1]. Because the activ-
ity of CaM in cells is tightly controlled and pools of 
otherwise free CaM are sequestered so as to restrict its 
availability for activating Ca2+/CaM-dependent en-
zymes, the name “calpacitin” was given to a family of 
neuronal proteins including Ng, growth associated 
protein 43 (GAP-43) and the small cerebel-
lum-enriched peptide PEP-19. All these proteins share 
a conserved IQ domain which is homologous to the 
CaM-binding domains of several other proteins. Ng is 
a specific protein kinase C (PKC) substrate and both 
the phosphorylation and oxidation of Ng significantly 
decrease Ng-CaM binding [2,3]. Furthermore, both 
phosphorylation and oxidation of Ng can mobilize 
intracellular Ca2+, hence increasing [Ca2+]i [4,5].  
Ng has been implicated in molecular mecha-
nisms underlying neuroplasticity and cognitive be-
havior. The concentration of Ng in hippocampus was 
observed to be correlated to the learning performance 
in adult mice [1]. After long-term potentiation (LTP) 
induction and during LTP maintenance, phosphoryla-
tion of Ng was increased in CA1 region of rat hippo-
campus [6, 7] whereas it was decreased in low fre-
quency induced long-term depression (LTD) [8]. 
NMDA can induce rapid and transient Ng oxidation 
in rat brain slice [9]. Knockout studies [10] showed 
that Ng deletion in mice did not show obvious devel-
opmental or neuroanatomical abnormalities but had 
significant impairment in hippocampus-dependent 
spatial learning paradigm as well as changes in the 
induction of hippocampal long-term and short-term 
plasticity. In addition, the hippocampal slices of Ng 
knockout mice displayed a reduced activation of 
Ca2+/CaM-dependent kinase II (CaMKII) and PKC 
isozymes, as well as PKA. Subsequently, phosphory-
lation of downstream targets, including ERK kinase 
(MEK), mitogen-activated protein kinase (MAPK) and 
cAMP response element binding protein (CREB) were 
also significantly attenuated in Ng knockout mice fol-
lowing NMDA treatment [11]. Therefore, Ng was 
proposed as an upstream modulator of multiple sig-
naling pathways in learning and memory [1]. 
In addition to its importance in regulating neu-
ronal Ca2+ homeostasis and Ca2+/CaM related signal-
ing pathway, Ng has also been found to be 
down-regulated in vitamin A-deficient animals and Int. J. Biol. Sci. 2007, 3 
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aging animals, whereas it is up-regulated in cytokine 
IL-2 deprived T-cell apoptosis [12]. Hence, Ng was 
proposed to be a pro-apoptotic factor [12]. These lines 
of evidence suggest that Ng may have other functions. 
Although the biochemical properties of Ng have 
been well studied, its physiological function and mo-
lecular mechanism are still not clearly elucidated. Pre-
vious attempt to identify the proteins interacting with 
Ng using yeast-two-hybrid technology has demon-
strated that CaM is the only major protein that inter-
acted with Ng in vivo [13]. Yeast two-hybrid experi-
ments are particularly useful in the detection of pair 
wise protein interactions but are limited in their ability 
to reveal the global protein constituents of protein 
complex/organelles of interest. The rapid develop-
ment of mass-spectrometric based proteomic tech-
niques has provided invaluable tools for studying the 
global protein profiles in various biological processes 
of complex organisms [14, 15, 16]. In the present study, 
we used isotope-coded affinity tag (ICAT) combined 
with 2-dimensional liquid chromatography/tandem 
mass spectrometry (2D-LC/MS/MS) to compare the 
difference of global pattern of protein expression be-
tween murine neuroblastoma cells (Neuro-2a) and 
Neuro-2a cells that stably expressed Ng 
(Neuro-2a-Ng). The Neuro-2a-Ng cells are very useful 
tool for the analysis of Ng function because there is no 
detectable expression of Ng in normal Neuro-2a cell. 
Expression differences among many functionally re-
lated proteins were identified in our results, which 
may account for the changes in morphology and dif-
ferentiation following expression of Ng in neuronal 
cells. Western blotting analysis of proteins from se-
lected functional groups confirmed the mass spec-
trometry results. The data reveal that Ng may play an 
important role in neuron development. 
2.  EXPERIMENTAL PROCEDURES 
Cell line and transfection 
Both Neuro-2a cells and human kidney embry-
onic 293 (HEK293) cells were routinely cultured in 
Dulbecco’s modified Eagle Medium (DMEM) (Invi-
trogen, USA) containing 1% v/v penicil-
lin-streptomycin (Gibcol, USA), 10% v/v fetal bovine 
serum (Clontech, USA), 25 mM of HEPES (Sigma, 
USA) and 3.7 g/l NaHCO3, pH 7.4-7.5. The Neuro-2a 
cells were transfected with pTRE-Tet-Ng and stably 
expressing Ng protein (Neuro-2a-Ng) [5]. The 
Neuro-2a-Ng cells were maintained in complete 
DMEM mentioned as above supplemented with 0.5 
mg/ml G418 (US Biological, USA). The cells were 
maintained at 37˚C with 5% CO2/95% room air, in 75 
cm2 tissue culture flasks (BD Falcon, USA). For serum 
withdraw induced differentiation, Neuro-2a and 
Neuro-2a-Ng cells cultured in similar density in nor-
mal complete DMEM were depleted of original me-
dium and washed with phosphate buffer saline (PBS) 
twice. Serum-free DMEM was added to the culture 
dishes and the cells were incubated in the same condi-
tions as previously described for 24 hr. Cell morphol-
ogy images were acquired under phase contrast mi-
croscope using 20 × objective lens. 
Transfection of HEK293 cells was carried out us-
ing modified calcium phosphate method. After 24 hr 
exposure to transfecting solution, cells were washed 
with culture medium, and Western blot experiments 
were conducted at the following 24 hr. 
Construction of pEGFP-Ng and in vitro site-directed 
mutagenesis 
Wild-type Ng cDNA was amplified from the ex-
pression plasmid pET3b-Ng [17] by PCR using 
5'-Forward and 3'-reverse oligonucleotides with de-
sired restriction sites (5' HindIII, 3' BamHI). The re-
striction-cleaved PCR product was ligated into the 
plasmid pEGFP-C2 (Clontech, CA, USA) and the en-
tire pEGFP-Ng coding region was checked for muta-
tions by cDNA sequencing. 
Site-directed mutations were incorporated into 
the Ng cDNA using the PCR-based QuickChange 
mutagenesis kit (Stratagene, La Jolla, CA). The suc-
cessful incorporation of the mutations was verified by 
DNA sequencing.   
Western Blot 
Neuro-2a and HEK293 cells were grown in 10 cm 
Petri-dishes and were washed with ice cold PBS twice. 
The cells were lysed with modified RIPA buffer which 
contained: 50 mM Tris-HCl pH7.4, 0.25% 
Na-deoxycholate, 150 mM NaCl, 1 mM EDTA, 1 mM 
phenylmethane-sulfonyl fluoride (PMSF), 1 µg/ml 
leupeptin, 1 µg/ml peptatin, 1 µg/ml aproptinin, 1 
mM NaF. Protein lysates were centrifuged at 12,000g 
for 15 min and the supernatant was collected for pro-
tein quantification by Bradford protein assay (Bio-Rad, 
USA). An aliquot of total protein of 10 µg was boiled 
and separated electrophorectically on 15% SDS-PAGE 
gel and transferred onto Hybond-N nitrocellulose 
membrane (GE Healthcare, USA) by electroblotting. 
After blocking in TBST buffer (25 mM Tris-HCl pH 7.4, 
1.5 M NaCl, 0.5% Tween-20) containing 5% fat-free 
dry milk for 1 hour, the nitrocellulose membrane 
sheets were incubated overnight at 4℃ with primary 
antibodies., After washing with TBST for five times, 
the membrane sheets were incubated with horserad-
ish-peroxidase conjugated anti-rabbit or anti-mouse 
IgG secondary antibody (1:5000, Sigma, USA) for 1 hr. 
The immunoreactive bands were visualized using GE 
Healthcare's ECL detection kit according to the 
manufacturer's instructions (GE Healthcare, USA). 
The primary antibodies used were affinity-purified 
polyclonal rabbit anti-Ng (Biogen, Germany), 
anti-phosphor-Ng (Biogen, Germany), anti-total 
ERK1/2 (Cell Signaling, USA), anti-α-tubulin (clone 
DM1A, Sigma, USA), anti-MAP1B (Sigma, USA) and 
anti-GAPDH (Cell Signaling, USA). All the primary 
antibodies were diluted at 1:1000. 
ICAT labeling 
The ICAT analysis of Neuro-2a control and 
Neuro-2a-Ng cells were carried out using the com-
mercially available cleavable ICAT Reagent Kit (Ap-
plied Biosystems, San Francisco, CA, USA) according Int. J. Biol. Sci. 2007, 3 
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to the instructions provided by manufacturer. Briefly, 
the cells were trypsinized and collected by centrifuga-
tion. The cell pellets were washed with ice cold PBS 
twice. Total proteins were dissolved in the denaturing 
buffer and equal amounts of proteins (100 µg) were 
used for ICAT analysis. After reduction and denatura-
tion, the Neuro-2a and Neuro-2a-Ng samples were 
labeled with biotin-conjugated 12C (light) and 13C 
(heavy) reagents at 37℃ for 2 hr, respectively. The 
two ICAT-labeled samples were combined and di-
gested with trypsin at a ratio of 1:10 with respect to 
the sample protein concentration at 37℃ for 12 to 16 
hr. The digest was acidified and loaded into a cation 
exchange column equilibrated with 10 mM 
KH2PO4/25% acetonitrile, pH 2.5-3.3. After neutrali-
zation, the biotinylated-ICAT-labeled peptides were 
purified by avidin affinity cartridge prepared as per 
the manufacturer’s instructions. ICAT-labeled pep-
tides were eluted with 30% acetonitrile, 0.4% 
trifluoroacetic acid in water. The eluted peptides were 
evaporated to dryness and reconstituted in 100 μl of 
cleavage reagent for 2h at 37°C to leave the biotin por-
tion of the tag from the labeled peptides. The cleaved 
peptides was lyophilized to dryness and stored at 
-20°C. 
2D-LC and MS/MS 
The ICAT labeled peptide mixture was separated 
using an UltimateTM dual-gradient liquid chromatog-
raphy (2D-LC)-system equipped with a ProbotTM 
MALDI spotting device. The 2D-LC equipments, 
columns and protocols were obtained from 
Dionex/LC Packings (San Francisco, CA, USA). 
Briefly, the separation was performed as follows: after 
acid cleavage, the dried ICAT peptide mixture was 
dissolved in 5mM KH2PO4 buffer (pH 3 adjusted with 
H3PO4) with 5% acetonitrile, and the samples were 
injected into a 0.3 × 150 mm strong cation- exchange 
(SCX) column (FUS-15-CP, Poros 10S) for the first di-
mension separation. The mobile phase A and B were 
5mM KH2PO4 buffer (pH 3 adjusted with H3PO4) with 
5% acetonitrile and 5mM KH2PO4 buffer (pH3, ad-
justed with H3PO4) with 5% acetonitrile, 500 mM KCl, 
respectively. The flow rate for the SCX column was 6 
μl/min. Nine fractions were separated by step gradi-
ents of mobile phase B (unbound, 0-5, 5-10, 10-15, 
15-20, 20-30, 30-40, 40-50, and 50-100%). The eluting 
fractions were captured alternatively by two 0.3 × 
1-mm trap column (3 µm C18 PepMapTM, 100 Å) and 
washed with 0.05% trifluroacetic acid, then eluted by 
gradient elution to a 0.2 × 50 mm reverse-phase col-
umn (Monolithic PS-DVB). The mobile phase A and B 
used for the second-dimension separation were 98% 
H2O, 2% acetonitrile with 0.05% trifluoroacetic acid 
and 80% H2O, 20% acetonitrile with 0.04% 
trifluoroacetic acid respectively. The gradient elution 
was 0-60% mobile phase B in 10 min. The flow rate 
was 2.7 µl/min. The LC fractions were mixed with 
MALDI matrix (7 mg/ml α-cyano-4-hydroxycinnamic 
acid and 130 µg/ml ammonium citrate in 75% ace-
tonitrile) in a flow rate of 5.4 µl/min through a 25 nl 
mixing tee (Upchurch Scientific) before spotting onto 
192-well stainless steel MALDI target plates (Applied 
Biosystems,) using a Probot Micro Fraction collector 
(Dionex- LC Packings), with a speed of 5 sec per well. 
Mass spectrometry analysis 
The samples on the MALDI target plates were 
analyzed using an ABI 4700 Proteomics Analyzer 
(Applied Biosystems) mass spectrometer with MALDI 
source and TOF/TOF™ optics. For 
mass-spectrometric (MS) analysis, typically 1000 shots 
were accumulated for each well of sample. MS/MS 
analyses were performed using nitrogen, at collision 
energy of 1 kV and a collision gas pressure of about 9 
× 10-7 Torr. A stop condition was used so that 3,000 to 
6,000 shots were combined for each spectrum de-
pending on the spectrum quality. 
MASCOT search engine (version 1.9; Matrix Sci-
ence Ltd, London, UK) was used to search all of the 
tandem mass spectra. GPS ExplorerTM software (ver-
sion 2.0, Applied Biosystems) was used to create and 
search files with the MASCOT search engine for pep-
tide and protein identifications. International protein 
index (IPI) mouse database was used for the search 
and was restricted to tryptic peptides. ICAT heavy or 
ICAT light labeled cysteine, N-terminal acetylation 
and pyroglutamation (E or Q), and methionine oxida-
t i o n  w e r e  s e l e c t e d  a s  v a r i a b l e  m o d i f i c a t i o n s .  O n e  
missing cleavage was allowed. Precursor error toler-
ance was set to <100 ppm and MS/MS fragment error 
tolerance < 0.3 Da. ICAT quantitation was done by the 
GPS ExplorerTM software and ICAT pair tolerance was 
set to 0.1 Da. 
Image analysis 
To examine the effect of the expression of Ng on 
the neurite growth, digital images of neurons in dif-
ferent conditions were taken using an inverted light 
microscope (Carl Zeiss, Göttingen, Germany) 
equipped with a digital camera (Nikon Coolpix 4500). 
Images of randomly-selected areas of neurons on con-
trol and Neuro-2a-Ng cells were taken at 20 × magni-
fications. The digital images of neurites from ran-
domly-selected image fields were analyzed using the 
Image-J program (National Institutes of Health, USA). 
Neurite outgrowth was quantified by counting the 
number of neurons in a culture that produced proc-
esses twice the diameter of the cell body. The per-
centage of neurite-bearing cells versus the total num-
ber of cells per culture for each condition was deter-
mined. The data was plotted as the mean and stan-
dard error for each treatment at a particular time point 
assuming each culture as n =1. 
3.  RESULTS 
Detection of Ng expression in Neuro-2a-Ng cells 
Before the ICAT experiments, Western blot was 
carried out to check for the expression level of Ng in 
the samples. In the experiments, 100 µg total proteins 
from Neuro-2a control and Neuro-2a-Ng cells were 
loaded. Previously we had reported the establishment 
of the stably transfected Neuro-2a cells. After transfec-
tion and screening, we had created four stable clones Int. J. Biol. Sci. 2007, 3 
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that expressed Ng [5]. To keep the consistency of ex-
periments and to ensure all cells have the same ex-
pression level of protein, we used only one of the 
Neuro-2a clones for all experiments carried out in this 
paper. Western blot results using Ng antibody indi-
cated there was an expression level comparable to 0.1 
µg purified Ng control in Neuro-2a-Ng as shown in 
Fig. 1B. Neuro-2a control cells did not show detectable 
level of Ng expression. The level of Ng expression 
could be maintained for three months (data not 
shown), indicating the Neuro-2a clone was stably 
transfected with Ng. Since the content of Ng in 
Neuro-2a-Ng cells is about 0.1% of total protein, 
which is close to the physiological concentration [1], 
Neuro-2a-Ng cells could be considered as a cell line 
expressing Ng and therefore be used for ICAT analy-
sis. 
 
Fig. 1. Cytoskeletal protein expression was down- 
regulated in Neuro-2a-Ng cells. A, A typical 
μLC/MS spectrum of an ICAT-labeled sample. 
Proteins from Neuro-2a-Ng cells were labeled with 
heavy 
13C reagent and those from Neuro-2a control 
were labeled with 
12C reagent. The 
13C/
12C ratio of 
this ICAT labeled molecular ion pair was 0.4, rep-
resenting the relative abundance of one peptide de-
rived from Neuro-2a-Ng and Neuro-2a. B, Western 
blot validation of ICAT mass spectrometry results. 
The identities and corresponding 
13C/
12C ratios for 
the protein in this figure are as follows: MAP1B (0.3), 
α-tubulin (0.5). GAPDH is loading control. GAPDH 
was used as the loading control (5 μg of pro-
tein/lane). 
 
ICAT analysis of Neuro-2a and Neuro-2a-Ng 
cells 
To assess changes in protein composition 
following the expression of Ng, the Neuro-2a 
control cells and Neuro-2a-Ng cells were ana-
lyzed by ICAT mass spectrometry. The ex-
tracted proteins from Neuro-2a control and 
Neuro-2a-Ng were labeled with light (12C) and 
heavy (13C) ICAT reagents, respectively; these 
two forms of ICAT reagent differ in mass by 9 
Da. Both versions of ICAT reagents contain a 
biotin tag, a thiol-reactive portion and a vari-
able linker region, which 12C- or 13C-labeled is 
used. In order to investigate the relative dif-
ferences in terms of protein expression, one 
sample is labeled with the 12C version and the other 
with the 13C. After covalent labeling, the two extracts 
were combined and digested with trypsin to produce 
tryptic peptides. The ICAT-labeled peptides were pu-
rified using the biotin tag present in the reagent and 
analyzed by two dimensional liquid chromatography- 
tandem mass spectrometry (2D-LC-MS/MS), produc-
ing daughter ion spectra by collision-induced disso-
ciation that can be analyzed by searching IPI database 
to reveal the identity of the protein from which they 
were digested.   
Pairs of light 12C- and heavy 13C-labeled peptides 
are chemically identical, are easily visualized because 
they essentially co-elute and display a 9Da mass dif-
ference measured in a scanning mass spectrometer. 
The relative quantitative change of each peptide is 
determined by relative differences in intensity of the 
12C and 13C-labeled peptides (but otherwise identical) 
(Fig. 1A). Previous experiments in our laboratory us-
ing equivalent proteome samples or mixture of stan-
dard proteins have suggested that ICAT measure-
ments have a standard deviation (SD) value of 10-20%. 
Based on this finding, the proteins whose abundance 
ratios (13C/12C) were equal to or greater than 1.5 were 
considered as significant increase (up-regulated) after 
Ng expression in Neuro-2a; whereas the proteins 
whose abundance ratio (13C/12C) were equal to or less 
than 0.67 were regarded as significant decrease 
(down-regulated) after Ng expression. Only those 
up-regulated or down-regulated proteins were in-
cluded in a target list for sequence analysis by 
2D-LC-MS/MS. Potentially unpaired ICAT peaks 
were also included in the list.   
A total of 103 unique peptides corresponding to 
55 proteins or polypeptides prepared from Neuro-2a 
control and Neuro-2a- Ng were identified and quanti-
tated, and of these 45% proteins showed significant 
changes. Table 1 shows a list of these proteins. We 
found that 72% of proteins in the list were 
down-regulated (H/L ratio less than 0.67), among Int. J. Biol. Sci. 2007, 3 
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which 50% are microtubule components and associ-
ated proteins. The rest of down-regulated proteins 
include heat shock proteins, translation and metabo-
lism related proteins and ubiquitin proteasome system 
proteins.  
Cytoskeletal protein expression was down- regulated in 
Neuro-2a-Ng cells 
F r o m  t h e  I C A T  r e s u l t s ,  m a n y  o f  t h e  
down-regulated proteins with the ratio less than 0.67 
are related with microtubule that is important for cell 
morphology, differentiation, proliferation and neurite 
outgrowth. Western blots of α tubulin and micro-
tubule associated protein 1B (MAP1B) were carried 
out in the two cell populations using specific primary 
antibodies. In order to distinguish the expression dif-
ference, low quantity of total protein (5 µg) was 
loaded. Consistent with ICAT mass spectrometry re-
sults, the expression level of both α tubulin and 
MAP1B was significantly reduced by 33% and 40%, 
respectively, in Neuro-2a-Ng cells. As the loading 
control, GAPDH expression level was equivalent in 
both cell populations (Fig.1B).   
Effect of Ng expression on the cell morphology of 
Neuro-2a cells 
Fig. 2A and 2B show the morphology of mouse 
Neuro-2a cell with and without the expression of Ng 
in serum containing medium. After 2 days in culture, 
most Neuro-2a cells were extending neuritis. However, 
Neuro-2a-Ng cells have relatively rounded cell bodies 
without neurites and were obviously less differenti-
ated. The percentage of neurite-bearing cells at 48 
hours is significantly lower in Neuro-2a-Ng cells than 
in Neuro-2a control (Fig. 2C). 
The morphological appearance of Neuro-2a and 
Neuro-2a-Ng cells after 24 hours of serum starvation, 
which induce Neuro-2a cell differentiation, is shown 
in Fig. 2D and 2E. Most Neuro-2a control cells have 
differentiated morphology characterized by rounded 
cell bodies with several projected neurites that often 
form branches and networks with others. In contrast 
to the multipolar type of neurite growth observed in 
Neuro-2a control cells, a large number of cells with 
expression of Ng have a distinct differentiated mor-
phology in which cell bodies extend only one or two 
long neurites that are generally unbranched. The per-
centage of neurite-bearing cells at 24 hours of serum 
starvation is significantly lower in Neuro-2a-Ng cells 
than in Neuro-2a control (Fig. 2F). This striking mor-
phological difference could be explained by a defect in 
neurite outgrowth which may be accounted for by 
defect in the cytoskeleton network.   
 
Fig. 2. Morphological effect of the expression of Ng in Neuro-2a cells. Neuro-2a-Ng displayed less differentiated appearance 
(B, E) compared to Neuro-2a control cells (A, D). After 24 hour serum deprivation, in contrast to the multipolar type of neurite 
growth observed in Neuro-2a control cells, a large number of Neuro-2a-Ng cells have a distinct differentiated morphology in 
which cell bodies extend only one or two long neurites that are generally unbranched. C and F are statistical analysis for 
neurite-bearing cells in both Neuro-2a and Neuro-2a-Ng without or with serum starvation, respectively. *p < 0.05 and **p < 
0.001. 
 
 Int. J. Biol. Sci. 2007, 3 
 
268
Table 1. List of proteins showing significantly altered expression in Neuro-2a-Ng cells 
Protein name  Accession No. Total Ion Score C.I. %  Averaged ICAT ratio*(H/L)
Up-regulated      
Gag IPI00118848  100  1.832 
Gag protein    IPI00466581  99.999  1.814 
T-complex protein 1 subunit epsilon  IPI00116279  99.378  1.826 
Similar to Hsp60, mitochondrial precursor  IPI00461249  56.155  1.663 
Heterogeneous nuclear ribonucleoprotein U  IPI00458583  99.895  1.547 
Similar to aspartate aminotransferase, mitochondrial precursor  IPI00475310  100  1.542 
Aspartate aminotransferase, mitochondrial precursor  IPI00117312  100  1.512 
      
Down-regulated      
Beta-centractin IPI00153990  73.581  0.681 
Tubulin beta-3  IPI00112251  99.993  0.67 
Tubulin beta-2c chain  IPI00169463  99.451  0.67 
Tubulin alpha-2 chain  IPI00551116  99.740  0.517 
Tubulin alpha-4 chain  IPI00117350  99.369  0.516 
Elongation factor 1-alpha 1  IPI00307837  98.991  0.561 
Elongation factor 2  IPI00466069  100  0.486 
Microtubule-associated protein 1B  IPI00130920  92.545  0.272 
Hsp105 IPI00224109  80.993  0.559 
Hsp70 IPI00331556  78.526  0.559 
GTP-binding nuclear protein Ran  IPI00134621  80.728  0.646 
Peptidyl-prolyl cis-trans isomerase  IPI00458341  100  0.619 
T-complex protein 1 subunit gamma  IPI00116283  90.604  0.591 
Tyrosine 3-monooxygenase/ tryptophan 5- monooxygenase activa-
tion protein, zeta polypeptide 
IPI00473203 99.88  0.562 
Ubiquitin carboxyl-terminal hydrolase isozyme L1  IPI00313962  100  0.515 
Isoform 1 of cellular nucleic acid binding protein  IPI00330767  96.078  0.478 
Fructose-bisphosphate aldolase A  IPI00221402  88.547  0 
Isoform 2 of zinc finger X-chromosomal protein  IPI00134496  31.306  0 
*H/L represents the abundance ratio between heavy isotope (13C) labeled proteins (Neuro-2a-Ng) and light isotope (12C) labeled proteins (Neuro-2a 
control). The averaged ICAT ratios equal to or higher than 1.5 (up-regulated expression) or, alternatively, equal to or lower than 0.7 (down-regulated 
expression) represent a significant change in protein expression in Neuro-2a-Ng cells relative to control cells. 
 
 
Fig. 3. The expression of Ng in-
duced sustained activation and 
up-regulation of ERK1/2 phos-
phorylation by PMA treatment in 
Neuro-2a-Ng cells. The time 
points after the treatment of 300 
nM PMA were shown above. The 
phosphorylation of ERK1/2, total 
ERK1/2 and Ng expression level 
were detected by Western blot 
analysis (10 μg of protein/lane) 
(A). The quantitation of Western 
blot images of the ratio between 
phospho-ERK1/2 and total-ERK 
was shown in B. *p < 0.05 and **p 
< 0.001, comparing Neuro-2a-Ng 
to Neuro-2a cells (n = 3). 
 
The expression of Ng induced 
sustained activation and 
up-regulation of ERK1/2 
phosphorylation by PMA 
treatment 
The above results sug-
gested that Ng may play an 
important role in cell differen-Int. J. Biol. Sci. 2007, 3 
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tiation and neurite growth. In order to test this hy-
pothesis, we focused on the effect of Ng expression in 
ERK signaling pathway. The ERK signaling pathway 
regulates crucial aspects of neuronal development, 
including cellular survival and differentiation [18]. 
Activation of ERK signaling pathway has also been 
found to alter dendrite and axonal growth in sympa-
thetic, sensory and spinal cord motor neurons and 
neurite outgrowth in PC12 cells [19, 20].   
Western blot analysis in Fig. 3 demonstrates the 
levels of ERK phosphorylation in Neuro-2a control 
and Neuro-2a-Ng cells after treatment with 300 nM 
PMA for 0, 10, 30, 60, 180, 360 min. PMA induced an 
increase in phosphorylation of ERK1/2 in a fluctuated 
way both in the Neuro-2a control and Neuro-2a-Ng 
cells, rising at 10 min then slightly decreasing at 60 
min followed by a second and continuous increase at 
180 min. Phosphorylation levels of ERK1/2 were sig-
nificantly higher at all time points in Neuro-2a-Ng 
cells compared to Neuro-2a control. The ratios be-
tween phospho-ERK1/2 and total-ERK were 2-4 folds 
elevated in Neuro-2a-Ng than Neuro-2a control.   
The similar results were also obtained in HEK 
293 cells transiently transfected with Ng. Fig 4 shows 
that there was an expression level comparable to 0.1 
µg Ng in HEK293 cells transfected with EGFP-Ng, 
whereas there was no detectable Ng expression in 
HEK293 cells transfected with EGFP only, which was 
considered as a control. In EGFP alone transfected 
cells, 300 nM PMA induced a fast and significant in-
crease in ERK1/2 phosphorylation at 10 min and the 
phosphorylation level peaked at 30 min and lasted up 
to 60 min. However, EGFP-Ng transfected cells exhib-
ited different pattern of ERK phosphorylation. The 
same PMA treating procedures produced a higher 
level of phosphorylated ERK peaked at 10 min, then 
gradually decreased in 30 and 60 min. Statistical 
analysis revealed that, at 10 min of PMA treatment, 
EGFP-Ng cells showed significant higher increase 
(two folds) in phosphorylated ERK1/2 level (p<0.005) 
than EGFP control cells. 
 
Fig. 4. Phosphorylation of ERK1/2 after 300 nM PMA treatment in HEK293 transiently transfected with EGFP or EGFP-Ng 
wild-type. The time points after the treatment of 300 nM PMA were shown above. The phosphorylation of ERK1/2, total 
ERK1/2, Ng expression level and the phosphorylation of Ng were detected by Western blot analysis (10 μg of protein/lane) 
(A). The quantitation of Western blot images of the ratio between phospho-ERK1/2 and total-ERK was shown in B. *p < 0.05 






Fig. 5. The ERK phosphorylation induced by PMA is medi-
ated by PKC. A, The pre-incubation with PKC specific in-
hibitor, 5 μM  GF102903X, totally abolished the ERK1/2 
phosphorylation induced by 300 nM PMA in HEK 293 
transfected with Ng wild type. B, Western blot analysis of 
ERK1/2 phosphorylation after 300 nM PMA treatment in 
HEK 293 transfected with Ng wild type, S36A and I33Q 
mutants. The time points after the treatment of PMA were 
shown above. 
 
PMA induced ERK phosphorylation is mediated by 
PKC 
Although PMA has been commonly used as a 
PKC activator, it was shown to have other receptors 
including mammalian α- and β-chimaerins [21, 22], 
Ras-GRP [23] and Caenorhabditis elegans Unc-13 [24]. 
In order to address whether the increase in ERK 
phosphorylation is mediated by PKC, PKC specific 
inhibitor GF102903X was applied to Neuro-2a-Ng cells. 
The immunoblot results in Fig. 5A shows pretreating 
with 5 µM GF102903X for 30 min almost blocked PMA 
induced ERK phosphorylation, indicating that PMA 
induced ERK phosphorylation in Neuro-2a-Ng cells is 
PKC-mediated. 
PKC is able to phosphorylate Ng through serine 
and it is also involved in ERK activation by various 
stimuli [25, 2]. In order to explore whether the phos-
phorylation of Ng would affect the status of ERK1/2 
phosphorylation, two mutations of Ng, S36A and I33Q, 
were used in present study. It has been reported that 
the mutation of S36A totally abolished the phos-
phorylation of Ng and I33Q mutation completely in-
hibited the interaction between Ng and CaM [13]. In-
terestingly, our results in Fig. 5B shows that HEK293 
cells with S36A mutant displayed sustained signifi-
cantly higher level of ERK1/2 phosphorylation than 
control even before PMA treatment. Surprisingly, 
there was not significant different between I33Q mu-
tant and wild type Ng in ERK1/2 phosphorylation 
degree throughout the whole time course. There was 
not any difference in total ERK1/2 levels between 
wild type Ng and either S36A or I33Q mutant. These 
results suggested that phosphorylation of Ng but not 
the binding ability with CaM played an important role 
in ERK activation. 
4.  Discussion 
With the utilization of 2D-LC and MS/MS in 
combination with ICAT labeling, the present study is 
the first report that identified a list of proteins whose 
expression were affected by the expression of Ng in 
Neuro-2a cells. Among the down-regulated proteins, 
40% are found to be either microtubule components or 
functionally related to microtubule assembly and sta-
bilization, neurite outgrowth and neuron morphology, 
suggesting possible defects in the cytoskeleton net-
work in Ng expressed cells. The Western blot results 
and image analysis of neurite growth in Neuro-2a-Ng 
support this conclusion. The expression of Ng in 
Neuro-2a cells induced a less differentiated morphol-
ogy than control cells. The serum deprivation caused 
the differentiation of Neuro-2a-Ng cells into largely 
unipolar or bipolar neurite-nearing cells which is quite 
different from the multipolar-type neurite outgrowth 
observed in Neuro-2a control cells. Western blots of 
MAP1B and α-tubulin demonstrated a dramatically 
decreased expression in Neuro-2a-Ng cells. These re-
sults imply that Ng may be involved in neuronal neu-
rite formation processes via regulation of microtubule 
and associated proteins. 
Neurites (including both axons and dendrites) 
are thin, elongated, dynamic, micro- tubule-based cell 
protrusions which form by active outgrowth from the 
cell body and terminate in a dynamic, actin-rich 
growth cone [27]. Microtubules are essential cy-
toskeletal polymers that are made of repeating α/β- 
tubulin heterodimers and are present in all eukaryotes. 
Microtubules affect cell morphology, cell transport, 
cell motility, cell proliferation and differentiation. All 
of these functions involve the interaction of micro-
tubules with a large number of microtubule-associated 
proteins (MAPs), which are important for the regula-
tion and distribution of microtubules in the cell. 
Microtubules are highly dynamic and can switch sto-
chastically between growing and shrinking phases, 
both in vivo and in vitro. This nonequilibrium behav-
ior, known as dynamic instability [28], is based on the 
binding and hydrolysis of GTP by tubulin subunits. 
Each tubulin monomer binds one molecule of GTP 
and the α-tubulin GTP is locked in the interface be-
tween α− and β-tubulins. Therefore, only the β-tubulin 
GTP undergoes exchange and hydrolysis. 
In the classic view microtubules play important 
roles in providing a scaffold for vesicle transport; 
however, recent studies in neuritogenesis have dis-
played microtubules as an important player in neurite 
initiation, morphogenesis and growth cone turning 
processes [27]. On the one hand, transport of specific 
signaling proteins down microtubules is critical for 
neurite initiation; on the other hand, microtubule dy-
namics in association with actin dynamics regulated Int. J. Biol. Sci. 2007, 3 
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by MAPs and a series of other proteins are required 
for neurite elongation. 
MAP1B is the first neuronal MAP to be expressed 
during the development of the nervous system [29, 30] 
and it is a major component of the neuronal cy-
toskeleton. Because the expression of MAP1B is 
down-regulated during brain development it was 
suggested that this protein could play a major role 
during neuron morphological differentiation, a role 
that disappears after neuron-neuron contacts are 
formed [31]. The preferential localization of MAP1B in 
the distal axonal portion, including the growth cone, 
suggested a role in axon outgrowth [32, 33, 34]. Addi-
tional evidence for this has come from the generation 
of several MAP1B mutant mice [35, 36, 37], despite 
some discrepancies concerning the severity of the re-
sulting phenotype. Thus, for example, cultured neu-
rons from hypomorphous MAP1B mutant mice that 
die at birth exhibit a defect in axonal outgrowth [38]. 
For another mutant mouse line [38], selective defects 
in the central and peripheral nervous systems have 
been observed that persist until adulthood. Further-
more, there is growing evidence that MAP1B is also 
important for axonal plasticity and regeneration in the 
adult nervous system [39, 40, 41].   
Our ICAT analysis showed various isoforms of 
α- and β-tubulin subunits dramatically decreased in 
the Ng expressed Neuro-2a cells. In addition, the pro-
teins related to microtubule dynamic function, such as 
MAP1B, RanGTPase and elongation factor, are also 
greatly reduced. This can explain the morphological 
difference between Neuro-2a and Neuro-2a-Ng cells, 
in which the former cells displayed more neurite out-
growth than the later one. It is interesting to note that 
the expression of MAP1B is abundant in the newborn 
brain and decrease with development. By immuno-
histochemistry MAP 1B was found to be highly con-
centrated in developing axonal processes in the cere-
bellar molecular layer, the corticospinal tract, the 
mossy fibers in the hippocampus, and the olfactory 
nerve. Of particular interest, the mossy fiber and ol-
factory nerve staining persisted in the adult, indicat-
ing continued outgrowth of the mossy fibers as well as 
olfactory nerve axons [31]. On the other hand, the ex-
pression of Ng in brain is also developmentally regu-
lated. The Northern blot analysis in cerebral neocortex 
showed that the amount of Ng mRNA was low during 
the prenatal period until postnatal day 8. It increased 
during postnatal development and reached its peak 
value at postnatal day 70 or postnatal month 6 [42]. 
After that, the amount of Ng mRNA in the cerebral 
neocortex decreased gradually until postnatal years 
2-3. In the hippocampus, in contrast to the results in 
the neocortex, the expression of Ng mRNA was de-
creased almost continuously during the postnatal pe-
riod. The expression pattern of Ng and MAP1B looks 
negatively correlated, implying these two elements 
probably behave as balancing factors in the modifica-
tion of neuron plasticity and brain development.   
Because of the special properties of Ng to bind 
CaM in a Ca2+-sensitive way and CaM is the only pro-
tein identified to interact with Ng yeast-hybrid ex-
periment, many studies have been focused on the 
roles of Ng in regulating Ca2+/CaM signaling in neu-
rons. Although Ca2+/CaM is very important in regula-
tion of many aspects of cell function, surprisingly little 
is known about its influence in MAP1B function. Some 
data suggest that Ca2+ homeostasis plays a role in the 
regulation of MAPs levels [43, 44]. Recently, Seiden-
becher et al. [45] reported that caldendrin, a neuronal 
Ca2+-sensor protein, specifically associates with the 
MAP1B via an interaction with light chain 3. CaM, 
however, is not capable of binding to light chain 3 
despite its high degree of primary structure similarity 
with caldendrin. Whether Ng could interact with 
other signaling molecular to modulate the level of 
MAP1B during brain development, in relation to 
normal neuronal differentiation and disorders associ-
ated with neurodegeneration is an interesting question 
and worth to explore additionally. 
To further investigate the role of Ng in cell 
growth and differentiation, we compared the ex-
tracellular-signal regulated kinase 1/2 (ERK1/2) ac-
tivity in Ng expressed cells with that in control. The 
present study is the first report demonstrated that the 
expression of Ng in both Neuro-2a and HEK293 cells 
led to enhanced ERK phosphorylation after treatment 
with PMA. A PKC specific inhibitor GF102903X was 
able to totally abolish the ERK phosphorylation by 
PMA, indicating that PMA activates ERK through 
PKC. 
The ERK1/2 is an evolutionarily conserved sig-
naling cascade and a member of mitogen-activated 
protein kinase (MAPK). It plays a crucial role in gene 
expression, cell growth, differentiation, and apoptosis 
through the activation of intracellular substrates, in-
cluding transcription factors and cytoskeletal proteins 
[46, 47]. ERK1/2 is activated by multiple extracellular 
stimuli, including growth factors and phorbol esters. 
The mechanisms of activation by various stimuli may 
differ, in part to control the strength and duration of 
the ERK response. PKC stimulation activates ERK 
through several pathways, including Ras-dependent 
and –independent mechanisms, that are not well un-
derstood [48]. It has been shown that PKC activation can be 
mediated by phospholipase C (PLC) [49, 50]. Our recent data 
exhibited that PMA raised intracellular Ca
2+ concentration 
by activating PKC through PLC (unpublished results). The 
increase in intracellular calcium level may serve as an 
indicator of PLC activation and a cofactor for PKC 
activation after PMA treatment. The sustained calcium 
mobilization in the cells may be an essential upstream 
signaling regulator for the sustained ERK activation. 
Our results in the mutant S36A, which abolished the 
phosphorylation of Ng by PKC, indicated that the 
basal level of ERK activity was increased even before 
PMA treatment, suggesting the phosphorylation of Ng 
by PKC inhibited ERK activation. It has been known 
the S36A has a slightly stronger interaction with CaM 
than native Ng, thus it also increased the intracellular 
free Ca2+ concentration. On the other hand, it is note-
worthy that I33Q mutant that completely inhibited the Int. J. Biol. Sci. 2007, 3 
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Ng’s interaction with CaM, showed similar ERK activ-
ity as Ng wild type, implying that Ng/CaM interac-
tion played little role in ERK activation. 
In summary, the proteomic analysis convey us a 
message that Ng may have many other aspects of 
functions which have not yet been discovered. For 
example, Ng has been found to be up-regulated in 
cytokine interleukin- 2 deprived T-cell apoptosis [12]. 
It is worthy of note that some up-regulated proteins in 
our ICAT result list, such as HSP60, T-complex protein 
1, heterogeneous nuclear ribonucleoprotein U and 
aspartate aminotransferase are related to DNA bind-
ing, protein folding, mitochondrion and regulation of 
apoptosis. Our present data provide the first evidence 
that Ng is involved in the regulation of ERK activity 
and neuronal skeleton network, suggesting its impor-
tant role in neuron growth and differentiation. 
ABBREVIATIONS  
Ng: neurogranin; CaM: calmodulin; ICAT: iso-
tope coded affinity tag; LC/MS/MS: liquid chroma-
tography and tandem mass spectrometry; PMA: 
12-myristate 13-acetate; ERK1/2: extracellular-signal 
regulated kinase; MAP1B: microtubule-associated 
protein 1B; GAPDH: glyceraldehyde-3-phosphate de-
hydrogenase. 
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